Respimat

{{short description|Drug delivery device used for the treatment of respiratory conditions}} 180px|thumb '''Respimat''', also known as '''Respimat Soft Mist Inhaler''', is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently{{when|date=August 2018}} conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.<ref>{{cite news |title=First reusable, propellant-free inhaler launched to cut plastic waste |url=https://www.pharmaceutical-journal.com/20207067.article |accessdate=19 November 2019 |publisher=Pharmaceutical Journal |date=17 September 2019}}</ref>

==References== {{Reflist}}

==Sources== * [http://www.respimat.com/ Home — Respimat International]

{{Dosage forms|state=expanded}}

Category:Drug delivery devices Category:Medical treatments

{{respiratory-system-drug-stub}}